Trident Texofab Limited (BOM:540726)

Trident Texofab Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.24	1.09	1.08	0.62	0.39	0.34
Short-Term Investments	-	30.02	-	-	-	-
Cash & Short-Term Investments	1.24	31.1	1.08	0.62	0.39	0.34
Cash Growth	-25.36%	2774.31%	75.65%	58.76%	12.79%	-57.93%
Accounts Receivable	484.45	407.09	366.73	338.73	308.54	302.77
Other Receivables	-	15.48	15.81	17.05	15.19	12.89
Receivables	552.2	435.08	382.54	355.78	323.73	316.61
Inventory	162.97	159.57	135.48	106.39	72.71	80.09
Prepaid Expenses	-	0.07	0.04	0.06	0.09	0.22
Other Current Assets	135.79	111.62	1.9	4.03	3.35	2.69
Total Current Assets	852.19	737.44	521.04	466.88	400.26	399.96
Property, Plant & Equipment	192.74	200.84	217.36	233.31	253.33	231.09
Long-Term Investments	65.38	18.95	37.4	36.4	20.59	32.41
Long-Term Deferred Charges	-	0.87	0.61	0.63	0.75	0.92
Other Long-Term Assets	24.65	47.66	42.57	35.87	34.96	13.22
Total Assets	1,135	1,006	818.98	773.07	709.88	677.74
Accounts Payable	150.99	148.57	166.91	176.23	113.87	162.18
Accrued Expenses	-	16.6	24.59	9.94	9.76	9.43
Short-Term Debt	-	162.52	162.43	131.39	131.34	99.6
Current Portion of Long-Term Debt	185.6	28.16	29.86	29.33	23.43	16
Current Portion of Leases	2.64	2.64	2.64	2.4	2.4	2.98
Current Income Taxes Payable	6.21	6.91	3.57	1	-	1.84
Other Current Liabilities	70.59	42.11	32.81	22.06	21.7	10.3
Total Current Liabilities	416.02	407.5	422.81	372.34	302.49	302.33
Long-Term Debt	100.7	74.29	177.36	188.76	220.24	204.76
Long-Term Leases	28.18	28.42	28.86	28.72	28.93	29.71
Long-Term Unearned Revenue	14.28	14.93	16.25	17.67	18.91	14.35
Pension & Post-Retirement Benefits	-	2.83	-	-	-	-
Long-Term Deferred Tax Liabilities	6.52	5.4	11.12	13.8	9.72	6.82
Other Long-Term Liabilities	-	0	-0	0	-	-
Total Liabilities	565.69	533.37	656.4	621.29	580.29	557.97
Common Stock	149.96	135.59	100.7	100.7	100.7	100.7
Additional Paid-In Capital	-	209.32	-	-	-	-
Retained Earnings	-	86.38	61.88	51.08	28.89	19.07
Comprehensive Income & Other	419.31	41.1	-	-	-	-
Total Common Equity	569.27	472.39	162.58	151.78	129.6	119.77
Shareholders' Equity	569.27	472.39	162.58	151.78	129.6	119.77
Total Liabilities & Equity	1,135	1,006	818.98	773.07	709.88	677.74
Total Debt	317.12	296.03	401.15	380.6	406.33	353.05
Net Cash (Debt)	-315.88	-264.93	-400.07	-379.98	-405.94	-352.71
Net Cash Per Share	-22.05	-22.65	-39.73	-37.73	-40.31	-35.30
Filing Date Shares Outstanding	14.65	13.56	10.07	10.07	10.07	10.07
Total Common Shares Outstanding	14.65	13.56	10.07	10.07	10.07	10.07
Working Capital	436.18	329.94	98.23	94.53	97.77	97.63
Book Value Per Share	38.87	34.84	16.14	15.07	12.87	11.89
Tangible Book Value	569.27	472.39	162.58	151.78	129.6	119.77
Tangible Book Value Per Share	38.87	34.84	16.14	15.07	12.87	11.89
Buildings	-	39.77	39.77	39.77	39.77	23.86
Machinery	-	218.77	218.81	219.02	186.37	113.25
Construction In Progress	-	-	-	-	36.22	88.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.